Anti-HIV drug dolutegravir failed to obtain Indian patent, case has been going on for many years
The Indian Patent Office has refused to grant a patent for dolutegravir. Dolutegravir is an important anti-HIV drug sold by Viv Healthcare. This will allow generic drugs to enter the market and become affordable. Will help expand access to life-saving treatments. The decision, announced after a contentious battle that lasted nearly a decade, comes after … Read more